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Purpose: To examine the myocilin (MYOC) gene for mutations in Japanese patients with primary open-angle glaucoma
(POAG) and to determine the phenotypes of the patients with the mutations.
Methods: One-hundred thirty-eight unrelated Japanese patients with POAG were studied. Genomic DNA was extracted
from leukocytes of peripheral blood, and the three coding exons including the intron-exon boundaries were amplified by
polymerase chain reaction (PCR) and directly sequenced bi-directionally.
Results: Two sequence variants were identified, one novel non-synonymous amino acid change (p.Gln297His) and one
reported synonymous amino acid change (p.Ala363Thr). These mutations were not detected in the 118 ethnically-matched
controls. p.Gln297His was found in a 70-year-old man, who developed POAG at a late age, and his intraocular pressure
was high. p.Ala363Thr was found in two cases, and both patients developed POAG at an early age and had high intraocular
pressures that responded poorly to medical treatment.
Conclusions: Two non-synonymous variants, p.Gln297His and p.Ala363Thr, indicate that they are involved in the
pathogenesis of POAG. p.Ala363Thr has been found in another Japanese population and would be useful in genetic testing.
Primary open-angle glaucoma (POAG) is a genetically
heterogeneous disorder characterized by a progressive
excavation of the optic disc and a loss of retinal nerve fiber
leading to visual field defects. It is most likely a genetically
heterogeneous disorder caused by the interaction of multiple
genes and environmental factors [1,2]. Adult onset POAG is
inherited as a complex trait while juvenile onset open-angle
glaucoma (JOAG) has an early onset with high penetrance and
an autosomal dominant mode of transmission [3].
To date, at least 14 loci from GLC1A to GLC1N have
been linked to POAG, and three genes have been identified,
the myocilin (MYOC) gene [4,5], the optineurin (OPTN) gene
[6], and the WD repeat domain 36 (WDR36) gene [7].
Mutations of MYOC have been found in sporadic and familial
cases of POAG worldwide, and their specific phenotype-
genotype correlation has been characterized [5,8-24]. Overall,
2%–4% of POAG cases are due to MYOC mutations [10,15],
although it might be as high as 22.2% [20] to 36% [18] in
families with JOAG. MYOC encodes 504 amino acid residues
[8] and is composed of three exons [25,26]. MYOC contains
a myosin-like domain and an olfactomedin-like domain, and
about 90% of the mutations are clustered in the region coding
for the olfactomedin-like domain in exon 3 [5,8,9,11].
The types of mutations found in diverse ethnic
populations are different, but the overall incidence of myocilin
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mutations is similar, which is about 2%–4% in all populations
[15]. The most common mutation of MYOC is the
p.Gln368Stop, which is found in Caucasians [12] and has not
been detected in Japanese. This would suggest that the
mutations in MYOC in the Japanese could be different from
that of Caucasians and perhaps other ethnic populations.
For the other two glaucoma genes (OPTN and WDR36),
the results of the screening were difficult to interpret. Thus,
the MYOC gene is the only glaucoma gene that has been
widely evaluated and is accepted to be a causal gene for
glaucoma in many populations. The purpose of this study was
to examine MYOC for mutations in Japanese patients with
primary open-angle glaucoma (POAG) and to determine the
phenotypes of the patients with these mutations.
METHODS
One-hundred thirty-eight unrelated Japanese patients with
POAG (72 men and 66 women; mean age 63.6±14.4 years),
who were examined at the Ophthalmic Clinic of the Tohoku
University Hospital, Sendai, Japan, were studied. The purpose
and procedures were explained to all patients, and an informed
consent was obtained. This study was approved by the Tohoku
University Institutional Review Board, and the procedures
used conformed to the tenets of the Declaration of Helsinki.
Routine ophthalmic examinations were performed on all
patients. The criteria used for classifying a patient as having
POAG were as follows: 1) applanation intraocular pressure
(IOP) greater than 22 mmHg in each eye; 2) glaucomatous
cupping in each eye including a cup-to-disc ratio greater than
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4130.7, 3) visual field defects determined by Goldmann perimetry
and/or Humphrey field analyzer consistent with the
glaucomatous cupping in at least one eye, and 4) an open
anterior chamber angle. The mean IOP at diagnosis was
27.2±5.1 mmHg in the 138 patients with POAG. Patients with
secondary glaucoma caused by trauma, uveitis, or steroid-
induced were excluded.
Control subjects (62 men and 56 women; mean age
68.0±7.7 years) had the following characteristics: 1) an IOP
of less than 22 mmHg, 2) normal optic discs, and 3) no family
history of glaucoma. The mean IOP at the initial examination
was 14.3±3.4 mmHg in the118 control patients.
Genomic DNA was extracted from peripheral blood
leukocytes and purified with the Qiagen QIAamp Blood Kit
(Qiagen, Valencia, CA). All three exons that code for a 504
amino acid protein were amplified by olymerase chain
reaction (PCR). For the PCR, seven primer sets were used
under standard PCR conditions (Table 1). The amplifications
were performed at 58 °C annealing temperature. PCR
fragments were purified by ExoSAP-IT (USB, Cleveland,
OH) and sequenced by the BigDyeTM Terminator Cycle
Sequencing Ready Reaction Kit (Perkin-Elmer, Foster City,
CA) on an automated DNA sequencer (ABI PRISMTM 3100
Genetic Analyzer, Perkin-Elmer).
RESULTS
Our results showed two MYOC variants. The first was a novel
MYOC variant, a missense mutation at the third nucleotide in
codon 297 (CAG>CAC) resulting in an amino acid
substitution of glutamine by histidine (p.Gln297His). The
second variant was a reported MYOC variant, a missense
mutation at the first nucleotide of codon 363 (GCT>ACT)
resulting in an amino acid substitution of alanine by threonine
(p.Ala363Thr) [24]. These mutations were not detected in all
normal controls.
TABLE 1. PRIMER SEQUENCES USED IN THIS STUDY.
Exon Primer name Primer sequence
Exon 1 MYOC1–1F GGCTGGCTCCCCAGTATATA
MYOC1–1R CTGCTGAACTCAGAGTCCCC
MYOC1–2F AATTGACCTTGGACCAGG
MYOC1–2R CTCCAGAACTGACTTGTCTC
Exon 2 MYOC2–1F ACATAGTCAATCCTTGGGCC
MYOC2–1R ATGAATAAAGACCATGTGGG
Exon 3 MYOC3–1F GGATTAAGTGGTGCTTCG
MYOC3–1R AATACGGGAACTGTCCGTGG
MYOC3–2F ATACTGCCTAGGCCACTGGA
MYOC3–2R CATGCTGCTGTACTTATAGCGG
MYOC3–3F GAACTCGAACAAACCTGGGA
MYOC3–3R TGAGCATCTCCTTCTGCC
The amplifications were performed at 58 °C annealing
temperature. PCR fragments were purified by ExoSAP-IT
(USB, Cleveland, OH) and sequenced by the BigDyeTM
Terminator Cycle Sequencing Ready Reaction Kit (Perkin-
Elmer, Foster City, CA) on an automated DNA sequencer
(ABI PRISMTM 3100 Genetic Analyzer, Perkin-Elmer).
Case 1 (p.Gln297His): Case 1 was a 71-year-old man
diagnosed with POAG at the age of 60 years. He has three
brothers and four sisters, but none of them has a glaucoma
history. His IOP at the time of diagnosis was 28 mmHg Oculus
Dexter (OD), and 45 mmHg Oculus Sinister (OD). He
underwent trabeculectomy in his left eye in 2002. In 2007, his
best corrected visual acuity (BCVA) in both eyes was 20/40
in the right eye and light perception in the left eye. The optic
disc showed characteristic glaucomatous changes with cup/
disc ratios of 0.9 in the right eye and 1.0 in the left eye. His
IOP was maintained between 20 and 24 mmHg in both eyes
under antiglaucoma medication. Global indices of the visual
field were a mean deviation (MD) of −7.48 dB by the
Humphrey field analyzer in the right eye. The visual fields of
the left eye could not be determined.
Case 2 (p.Ala363Thr): Case 2 was a 60-year-old woman
who was diagnosed with POAG in 1970 at the age of 24 years
(Figure 1). She underwent trabeculectomy four times in her
right eye and twice in her left eye from 1980 to 1981. In 1993,
the visual acuity of her right eye and left eye was hand motion
and counting finger, respectively. The optic discs had the
characteristic changes of glaucoma with a cup/disc ratio of 1.0
OD and 0.9 OS. Her IOP was maintained between 15 and
18 mmHg in both eyes with antiglaucoma medication. Her
sisters and brother also had glaucoma that was diagnosed
before the age of 40 years (Figure 1), but no further medical
record and no blood sample was available.
The daughter of the proband was first examined for
glaucoma in 1999 at the age of 24. Her BCVA was 30/20
Oculus Uterque (OU). Her IOP were 22 mmHg in both eyes.
The optic disc was excavated with the cup/disc ratio of 0.8 in
both eyes. Automated static perimetry (Humphrey; program
30–2) revealed a nasal step. Treatment was started with topical
antiglaucomatous medications, and her IOP was maintained
between 16 and 19 mmHg. Her father and sister were also
examined and found not to have any mutations in MYOC.
Figure 1. Pedigree of Case 2. Solid squares indicate the affected men,
and solid circles indicate the affected women. An arrow points to the
proband. The gray square indicates the ocular hypertension and
glaucoma suspect. The family included six affected individuals.
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414Case 3 (p.Ala363Thr): This patient was a 65-year-old
woman diagnosed with POAG at the age of 44 years. Her
brother had also been diagnosed with glaucoma (Figure 2) at
the age of 48. As for her mother, no medical record was
available regarding the age at diagnosis.
Her IOP at the time of diagnosis was 22–24 mmHg in
both eyes. Her BCVA was 20/20 OU. The optic disc showed
the characteristic glaucomatous changes in the right eye with
a cup/disc ratio of 0.9–1.0, but the ratio was 0.2 in the left eye.
Her IOP was maintained around 20 mmHg in both eyes with
antiglaucoma medication. She did not undergo glaucoma
surgery. In 2007, the optic disc showed optic atrophy with the
full cupping in both eyes. Her visual acuity was hand motion
in the right eye and 20/200 in the left eye. Goldmann perimetry
showed paracentral residual visual fields in the right eye and
absolute scotomas in more than one quadrant in the left eye.
The proband and her brother were found to have the same
p.Arg363Thr mutation.
DISCUSSION
Our analyses detected two variants of MYOC in our Japanese
patients with POAG. A novel MYOC variant, p.Gln297His,
and a variant, p.Arg363Thr [19,24], which was reported
earlier in Japanese patients, were found. The phenotypes of
our POAG patients with the two variants were moderate to
high IOP, aggressive course without treatment, poor response
to topical medication, and moderate response to filtration
surgery. The phenotype in these patients is consistent with the
phenotype presented for other GLC1A families [3,27-33].
In general, Japanese patients with POAG caused by a
MYOC mutation such as p.Pro370Leu [16] and p.Thr448Pro
Figure 2. Pedigree of Case 3. Solid circles indicate the proband and
affected mother, and the solid square indicates the affected brother.
The white square indicates the father, who is an unaffected subject.
[17,23] show early-onset at the age 40 years or younger. On
the other hand, the POAG caused by a p.Ile360Asn [21]
mutation has a late-onset phenotype as it is with the
p.Gln368Stop mutation found in Western countries [12,34].
The p.Ala363Thr was segregated as an autosomal dominant
mutation (Figure 1 and Figure 2), and MYOC orthologs were
conserved in humans, chimpanzees, rats, mice, and dogs
(Figure 3). p.Gln297His alters the amino acid sequence on the
charge (neutral to basic), and p.Ala363Thr alters the amino
acid sequence on the polarity (nonpolar to polar). Thus, the
conservation of MYOC orthologs and changes that alter the
charge and polarity can be considered to be probable disease-
causing mutations. However, the subject who had the
p.Gln297His mutation did not show family history.
About 90% of the mutations are clustered in exon 3 of
MYOC in different ethnic populations [15], and this incidence
is the same in the Japanese population (Figure 4). In this study,
MYOC mutations were found at the rate of 3/136 (2.2%),
which is approximately the same as previous reports on the
Japanese and other ethnic populations [15,19]. The
p.Ala363Thr mutation was found in another Japanese
population and thus may be useful to examine in genetic
screening tests [19,24].
Figure 3. Multiple amino acid alignments and evolutionary
conservation of p.Gln297 and p.Arg363 of MYOC variants. Protein
domains of MYOC are shown. Gln297 and Arg363 (underlined) are
conserved among five species, humans, chimpanzees, rats, mice, and
dogs.
Figure 4. Mutation spectrum found in Japanese individuals. The
black boxes indicate the three exons. Nine out of 11 mutations are
located in exon 3, the olfactomedin-like domain. The two underlined
mutations were found in this study.
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detection even before the elevation of IOP or the irreversible
visual impairment due to damage of the optic nerve. More
studies of the function and genotype-phenotype correlation of
the MYOC gene are required to determine the
pathophysiology of POAG.
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